arrow
F

Franco Trevisani

italian liver cancer association
H指数:74
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测因子:一项多中心观察性研究

2026-01-140
PRE
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测指标:一项观察性多中心研究

2026-01-140
PRE
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测因子:一项多中心观察性研究

2026-01-140
PRE
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测指标:一项观察性多中心研究

2026-01-140
PRE
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测指标:一项观察性多中心研究

2026-01-140
PRE
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

肿瘤负荷评分作为肝细胞癌经动脉化疗栓塞术后肝外进展的预测指标:一项多中心观察性研究

2026-01-140
PRE
Outcome of hepatic resection for HCC in ideal and non-ideal candidates

理想和非理想候选者行肝切除治疗HCC的结局

2025-07-290
OA
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma

系统性炎症反应标志物提高了肝细胞癌预后模型的鉴别能力

2025-03-251
OA
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma

丙型肝炎病毒复制缺失与抗HCV阳性肝细胞癌患者预后改善相关

2025-01-080
OAAI
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care

索拉非尼和节律性卡培他滨在Child-Pugh B级晚期肝癌患者中的应用: 与最佳支持治疗的现实比较

2024-09-014
PRE
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib
2024-03-292
OAAI
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma
2024-03-012
OAAI